Annual Total Long Term Liabilities
$450.02 M
-$12.09 M-2.62%
December 31, 2023
Summary
- As of February 8, 2025, FOLD annual total long term liabilities is $450.02 million, with the most recent change of -$12.09 million (-2.62%) on December 31, 2023.
- During the last 3 years, FOLD annual total long term liabilities has fallen by -$20.45 million (-4.35%).
- FOLD annual total long term liabilities is now -20.45% below its all-time high of $565.74 million, reached on December 30, 2016.
Performance
FOLD Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$449.59 M
+$699.00 K+0.16%
September 30, 2024
Summary
- As of February 8, 2025, FOLD quarterly total long term liabilities is $449.59 million, with the most recent change of +$699.00 thousand (+0.16%) on September 30, 2024.
- Over the past year, FOLD quarterly long term liabilities has dropped by -$11.80 million (-2.56%).
- FOLD quarterly long term liabilities is now -21.54% below its all-time high of $573.01 million, reached on March 31, 2017.
Performance
FOLD Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
FOLD Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.6% | -2.6% |
| 3 y3 years | -4.3% | -2.6% |
| 5 y5 years | +24.7% | -2.6% |
FOLD Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.6% | at low | -2.8% | +0.2% |
| 5 y | 5-year | -4.3% | +83.7% | -4.4% | +93.6% |
| alltime | all time | -20.4% | >+9999.0% | -21.5% | >+9999.0% |
Amicus Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $449.59 M(+0.2%) |
| Jun 2024 | - | $448.89 M(-0.0%) |
| Mar 2024 | - | $448.99 M(-0.2%) |
| Dec 2023 | $450.02 M(-2.6%) | $450.02 M(-2.5%) |
| Sep 2023 | - | $461.39 M(+0.5%) |
| Jun 2023 | - | $459.28 M(-0.1%) |
| Mar 2023 | - | $459.56 M(-0.5%) |
| Dec 2022 | $462.10 M(+2.3%) | $462.10 M(-0.0%) |
| Sep 2022 | - | $462.31 M(-0.0%) |
| Jun 2022 | - | $462.54 M(+0.9%) |
| Mar 2022 | - | $458.62 M(+1.5%) |
| Dec 2021 | $451.80 M(-4.0%) | $451.80 M(-1.6%) |
| Sep 2021 | - | $458.94 M(-0.4%) |
| Jun 2021 | - | $460.99 M(+0.3%) |
| Mar 2021 | - | $459.49 M(-2.3%) |
| Dec 2020 | $470.46 M(+92.0%) | $470.46 M(+0.4%) |
| Sep 2020 | - | $468.55 M(+101.8%) |
| Jun 2020 | - | $232.20 M(-4.9%) |
| Mar 2020 | - | $244.04 M(-0.4%) |
| Dec 2019 | $244.97 M(-32.1%) | $244.97 M(+1.7%) |
| Sep 2019 | - | $240.94 M(+5.5%) |
| Jun 2019 | - | $228.43 M(-7.6%) |
| Mar 2019 | - | $247.16 M(-31.5%) |
| Dec 2018 | $360.91 M(+76.8%) | $360.91 M(-0.2%) |
| Sep 2018 | - | $361.76 M(+71.4%) |
| Jun 2018 | - | $211.03 M(+1.6%) |
| Mar 2018 | - | $207.68 M(+1.7%) |
| Dec 2017 | $204.13 M(-63.9%) | $204.13 M(+0.6%) |
| Sep 2017 | - | $202.94 M(-64.5%) |
| Jun 2017 | - | $571.39 M(-0.3%) |
| Mar 2017 | - | $573.01 M(+1.3%) |
| Dec 2016 | $565.74 M(+16.2%) | $565.74 M(+14.1%) |
| Sep 2016 | - | $496.01 M(-0.7%) |
| Jun 2016 | - | $499.30 M(+2.6%) |
| Mar 2016 | - | $486.85 M(-0.0%) |
| Dec 2015 | $486.93 M | $486.93 M(-14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $572.07 M(+884.5%) |
| Jun 2015 | - | $58.11 M(-14.0%) |
| Mar 2015 | - | $67.58 M(-0.0%) |
| Dec 2014 | $67.60 M(-5.3%) | $67.60 M(-1.1%) |
| Sep 2014 | - | $68.39 M(-3.0%) |
| Jun 2014 | - | $70.52 M(-1.9%) |
| Mar 2014 | - | $71.91 M(+0.8%) |
| Dec 2013 | $71.35 M(+125.6%) | $71.35 M(+109.7%) |
| Sep 2013 | - | $34.02 M(+3.7%) |
| Jun 2013 | - | $32.81 M(+2.9%) |
| Mar 2013 | - | $31.88 M(+0.8%) |
| Dec 2012 | $31.63 M(+51.0%) | $31.63 M(+0.3%) |
| Sep 2012 | - | $31.52 M(+52.9%) |
| Jun 2012 | - | $20.62 M(-7.4%) |
| Mar 2012 | - | $22.26 M(+6.3%) |
| Dec 2011 | $20.95 M(-33.3%) | $20.95 M(-10.7%) |
| Sep 2011 | - | $23.45 M(-18.6%) |
| Jun 2011 | - | $28.80 M(-12.3%) |
| Mar 2011 | - | $32.85 M(+4.6%) |
| Dec 2010 | $31.39 M(+1239.4%) | $31.39 M(+512.8%) |
| Sep 2010 | - | $5.12 M(+51.7%) |
| Jun 2010 | - | $3.38 M(-33.8%) |
| Mar 2010 | - | $5.11 M(+117.8%) |
| Dec 2009 | $2.34 M(-94.7%) | $2.34 M(-94.8%) |
| Sep 2009 | - | $44.65 M(-0.3%) |
| Jun 2009 | - | $44.80 M(+2.8%) |
| Mar 2009 | - | $43.56 M(-1.8%) |
| Dec 2008 | $44.35 M(-7.6%) | $44.35 M(-1.9%) |
| Sep 2008 | - | $45.21 M(-2.0%) |
| Jun 2008 | - | $46.12 M(-2.0%) |
| Mar 2008 | - | $47.04 M(-2.0%) |
| Dec 2007 | $48.01 M(-62.2%) | $48.01 M(+2951.9%) |
| Sep 2007 | - | $1.57 M(-19.5%) |
| Jun 2007 | - | $1.95 M(-98.7%) |
| Mar 2007 | - | $150.76 M(+18.8%) |
| Dec 2006 | $126.95 M(+105.1%) | $126.95 M(+105.1%) |
| Dec 2005 | $61.91 M | $61.91 M |
FAQ
- What is Amicus Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics annual total long term liabilities year-on-year change?
- What is Amicus Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly long term liabilities year-on-year change?
What is Amicus Therapeutics annual total long term liabilities?
The current annual total long term liabilities of FOLD is $450.02 M
What is the all time high annual total long term liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total long term liabilities is $565.74 M
What is Amicus Therapeutics annual total long term liabilities year-on-year change?
Over the past year, FOLD annual total long term liabilities has changed by -$12.09 M (-2.62%)
What is Amicus Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of FOLD is $449.59 M
What is the all time high quarterly long term liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total long term liabilities is $573.01 M
What is Amicus Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, FOLD quarterly total long term liabilities has changed by -$11.80 M (-2.56%)